[Your role / profession] - A Computer Engineering student and aspiring AI/ML researcher deeply interested in longevity science, aging biology, healthspan extension, and the application of artificial intelligence to aging research [Keep] - Major new research findings on the biology and mechanisms of aging - Clinical trial results involving interventions targeting aging or age-related biological processes - Breakthroughs in partial cellular reprogramming, epigenetic rejuvenation, senolytics, rapamycin, NAD+ metabolism, gene therapy, and regenerative medicine - Research on biological age, epigenetic clocks, aging biomarkers, and multi-omics approaches including genomics, transcriptomics, proteomics, and methylation - Advances in AI and machine learning applications for aging research, biological age prediction, drug discovery, and longevity interventions - Important datasets, computational tools, models, or open-source projects relevant to aging biology and longevity research - News from major longevity companies, research labs, startups, and prominent researchers - FDA approvals, major clinical milestones, significant funding rounds, or major partnerships related to longevity biotechnology - High-quality systematic reviews, meta-analyses, and landmark papers on aging and longevity interventions - Major discoveries related to lifespan extension, healthspan improvement, cellular senescence, age-related diseases, and mechanisms of rejuvenation [Filter out] - Generic wellness, diet, exercise, or lifestyle advice without strong scientific relevance to aging research - Marketing content for supplements, anti-aging products, or treatments without solid clinical evidence - Celebrity anti-aging routines, beauty industry news, skincare trends, or cosmetic procedures - Sensationalized longevity claims without credible scientific evidence - Low-quality studies, press releases that exaggerate findings, or purely speculative anti-aging content